Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hank Mansbach

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|December 6, 2023
Randomized Trial of Pegozafermin in NASH. ReplyRohit Loomba, Hank Mansbach, Maya Margalit
Neurology|August 12, 2004
Predicting the response to sumatriptan: the Sumatriptan Naratriptan Aggregate Patient DatabaseHans Christoph-Diener, Michel Ferrari, Hank Mansbach, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2024
Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels-authors' replyNaim Alkhouri, Leo Tseng, Kemal Balic, et al.
Epilepsy Research|September 18, 2012
Bioavailability of intranasal vs. rectal diazepamVijay Ivaturi, Robert Kriel, Richard Brundage, et al.
Neurology. Genetics|March 8, 2019
<i>GNE</i> genotype explains 20% of phenotypic variability in GNE myopathyOksana Pogoryelova, Ian J Wilson, Hank Mansbach, et al.
Clinical Pharmacology and Therapeutics|September 11, 2023
Population Pharmacokinetics and Pharmacodynamics of Pegozafermin in Patients with Nonalcoholic SteatohepatitisChih-Ming Leo Tseng, Kemal Balic, R Will Charlton, et al.
Journal of the American College of Cardiology|May 14, 2025
Target Populations for Novel Triglyceride-Lowering TherapiesAsk T Nordestgaard, Anne Tybjærg-Hansen, Hank Mansbach, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 10, 2023
The Novel GlycoPEGylated FGF21 Analog Pegozafermin Activates Human FGF Receptors and Improves Metabolic and Liver Outcomes in Diabetic Monkeys and Healthy Human VolunteersMoti Rosenstock, Leo Tseng, Andrew Pierce, et al.
Headache|September 28, 2004
Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark StudyStewart J Tepper, Carl G H Dahlöf, Andrew Dowson, et al.
Neuromuscular Disorders : NMD|January 7, 2018
Phenotypic stratification and genotype-phenotype correlation in a heterogeneous, international cohort of GNE myopathy patients: First report from the GNE myopathy Disease Monitoring Program, registry portionOksana Pogoryelova, Phillip Cammish, Hank Mansbach, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|December 6, 2023
Randomized Trial of Pegozafermin in NASH. ReplyRohit Loomba, Hank Mansbach, Maya Margalit
Neurology|August 12, 2004
Predicting the response to sumatriptan: the Sumatriptan Naratriptan Aggregate Patient DatabaseHans Christoph-Diener, Michel Ferrari, Hank Mansbach, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2024
Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels-authors' replyNaim Alkhouri, Leo Tseng, Kemal Balic, et al.
Epilepsy Research|September 18, 2012
Bioavailability of intranasal vs. rectal diazepamVijay Ivaturi, Robert Kriel, Richard Brundage, et al.
Neurology. Genetics|March 8, 2019
<i>GNE</i> genotype explains 20% of phenotypic variability in GNE myopathyOksana Pogoryelova, Ian J Wilson, Hank Mansbach, et al.
Clinical Pharmacology and Therapeutics|September 11, 2023
Population Pharmacokinetics and Pharmacodynamics of Pegozafermin in Patients with Nonalcoholic SteatohepatitisChih-Ming Leo Tseng, Kemal Balic, R Will Charlton, et al.
Journal of the American College of Cardiology|May 14, 2025
Target Populations for Novel Triglyceride-Lowering TherapiesAsk T Nordestgaard, Anne Tybjærg-Hansen, Hank Mansbach, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 10, 2023
The Novel GlycoPEGylated FGF21 Analog Pegozafermin Activates Human FGF Receptors and Improves Metabolic and Liver Outcomes in Diabetic Monkeys and Healthy Human VolunteersMoti Rosenstock, Leo Tseng, Andrew Pierce, et al.
Headache|September 28, 2004
Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark StudyStewart J Tepper, Carl G H Dahlöf, Andrew Dowson, et al.
Neuromuscular Disorders : NMD|January 7, 2018
Phenotypic stratification and genotype-phenotype correlation in a heterogeneous, international cohort of GNE myopathy patients: First report from the GNE myopathy Disease Monitoring Program, registry portionOksana Pogoryelova, Phillip Cammish, Hank Mansbach, et al.
Pageof 2